A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2001

Conditions

Pain, PostoperativeOrthopedic ProceduresAnalgesia

Interventions

DRUG

OROS hydromorphone HCI

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY